Relation of the neuroendocrine system to the development and growth of experimental mammary tumors.
The regulation of hormonal influences on mammary tumor development and growth resides in the hypothalamus. The two major hormones essential for mammary tumor development in the rat and mouse, and also for mammary tumor growth in the rat, are prolactin and estrogen. Prolactin secretion is directly controlled by the hypothalamus, and estrogen indirectly via the pituitary gonadotropins. Treatments that increase prolactin secretion in the rat and mouse increase the incidence of spontaneous mammary tumors, whereas treatments that decrease prolactin or estrogen secretion decrease the incidence of spontaneous mammary tumors in these species. In carcinogen treated rats, either an increase or decrease in prolactin or ovarian hormones inhibits development of mammary cancers. After the appearance of mammary tumors in rats, spontaneous or carcinogen-induced, a reduction in prolactin results in reduced mammary tumor growth, and an increase in prolactin in enhanced mammary tumor growth. Either a reduction in estrogen or an excess of estrogen inhibits mammary tumor growth in rats. Large doses of estrogen inhibit mammary tumor growth by preventing prolactin from stimulating tumor growth. In mice with well established mammary tumors, prolactin or estrogen have relatively little effect since these tumors are largely autonomous.
D015127:9,10-Dimethyl-1,2-benzanthracene; D000109:Acetylcholine / Q000502:physiology; D000818:Animals; D001943:Breast Neoplasms / Q000503:physiopathology; D004298:Dopamine / Q000502:physiology; D004967:Estrogens / Q000502:physiology*; D004978:Ethamoxytriphetol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007031:Hypothalamus / Q000502:physiology*; D007774:Lactation; D007980:Levodopa / Q000627:therapeutic use; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology*; D051379:Mice; D010053:Ovary / Q000502:physiology; D010903:Pituitary Gland, Anterior / Q000502:physiology; D011247:Pregnancy; D011388:Prolactin / Q000378:metabolism / Q000502:physiology*; D011389:Prolactin Release-Inhibiting Factors / Q000502:physiology; D051381:Rats; D012701:Serotonin / Q000502:physiology; D013973:Thyrotropin-Releasing Hormone / Q000502:physiology
D004967:Estrogens; D012701:Serotonin; D007980:Levodopa; D015127:9,10-Dimethyl-1,2-benzanthracene; D013973:Thyrotropin-Releasing Hormone; D004978:Ethamoxytriphetol; D011388:Prolactin; D011389:Prolactin Release-Inhibiting Factors; D000109:Acetylcholine; D004298:Dopamine